Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Regado Biosciences
company
About
Regado Biosciences develops antithrombotic drug systems for acute and sub-acute cardiovascular and other indications.
- 11 - 50
Details
- Last Funding Type
- Series E
- Last Funding Money Raised
- $51M
- Industries
- Biotechnology,Health Care,Therapeutics
- Founded date
- Jan 1, 2001
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Regado Biosciences is a biopharmaceutical company, engages in the discovery and development of aptamer-based antidote-controlled therapeutics. It provides REG1 that is used in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures, which include coronary artery bypass grafting and percutaneous coronary intervention. It was founded in 2001 and headquartered in Durham, North Carolina.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$114M
Regado Biosciences has raised a total of
$114M
in funding over 2 rounds. Their latest funding was raised on
Dec 17, 2012 from a Series E round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 17, 2012 | Series E | $51M | 1 | — | — | Detail |
| Dec 17, 2009 | Series D | $40M | 1 | — | — | Detail |
| Mar 27, 2007 | Series C | $23M | 1 |
Caxton Advantage Life Sciences Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Regado Biosciences is funded by 1 investors.
Caxton Advantage Life Sciences Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Caxton Advantage Life Sciences Fund
|
— | Series E |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
